Bcl-2 is most famously associated with certain types of lymphomas, such as follicular lymphoma and chronic lymphocytic leukemia (CLL). It is also implicated in other cancers, including breast cancer, prostate cancer, and non-small cell lung cancer. In these cancers, Bcl-2 helps the malignant cells evade apoptosis, contributing to the disease's progression and resistance to therapy.
